Cetera Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.7M | Buy |
|
|||||
|
2023
Q4 | $1.09M | Sell |
|
|||||
|
2023
Q3 | $1.22M | Sell |
|
|||||
|
2023
Q2 | $3.36M | Sell |
|
|||||
|
2023
Q1 | $3.57M | Sell |
|
|||||
|
2022
Q4 | $3.54M | Buy |
|
|||||
|
2022
Q3 | $2.41M | Buy |
|
|||||
|
2022
Q2 | $4.24M | Sell |
|
|||||
|
2022
Q1 | $4.25M | Buy |
|
|||||
|
2021
Q4 | $3.8M | Sell |
|
|||||
|
2021
Q3 | $3.75M | Buy |
|
|||||
|
2021
Q2 | $3.05M | Buy |
|
|||||
|
2021
Q1 | $2.59M | Buy |
|
|||||
|
2020
Q4 | $2.43M | Buy |
|
|||||
|
2020
Q3 | $1.75M | Buy |
|
|||||
|
2020
Q2 | $1.25M | Buy |
|
|||||
|
2020
Q1 | $1.14M | Sell |
|
|||||
|
2019
Q4 | $2.59M | Sell |
|
|||||
|
2019
Q3 | $2.4M | Buy |
|
|||||
|
2019
Q2 | $2.04M | Buy |
|
|||||
|
2019
Q1 | $2.09M | Buy |
|
|||||
|
2018
Q4 | $643K | Buy |
|
|||||
|
2018
Q3 | $543K | Buy |
|
|||||
|
2018
Q2 | $209K | Sell |
|
|||||
|
2018
Q1 | $267K | Buy |
|
|||||
|
2017
Q4 | $231K | Buy |
|
|||||
|
2017
Q3 | $237K | Sell |
|
|||||
|
2017
Q2 | $672K | Sell |
|
|||||
|
2017
Q1 | $653K | Buy |
|
|||||
|
2016
Q4 | $372K | Buy |
|
|||||
|
2016
Q3 | $391K | Sell |
|
|||||
|
2016
Q2 | $407K | Buy |
|
|||||
|
2016
Q1 | $365K | Sell |
|
|||||
|
2015
Q4 | $726K | Sell |
|
|||||
|
2015
Q3 | $731K | Buy |
|
|||||
|
2015
Q2 | $751K | Buy |
|
|||||
|
2015
Q1 | $729K | Buy |
|
|||||
|
2014
Q4 | $434K | Buy |
|
|||||
|
2014
Q3 | $273K | Buy |
|
|||||
|
2014
Q2 | $304K | Buy |
|
|||||
|
2014
Q1 | $214K | Buy |
|